A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01565655 · COMPLETED
Trial details
- NCT number
- NCT01565655
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-19
- Primary completion
- 2013-12-02
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.